Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reshape Lifesciences Inc (NQ: RSLS ) 5.600 +0.220 (+4.09%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Reshape Lifesciences Inc < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > 12 Health Care Stocks Moving In Thursday's After-Market Session December 15, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday November 29, 2022 On Tuesday, 89 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 29, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 16, 2022 Via Benzinga ReShape Lifesciences' GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Procedures August 10, 2022 Via Benzinga ReShape Lifesciences(TM) (NASDAQ: RSLS) Featured in Coverage of Investor Summit Group’s Q4 Event November 15, 2022 Via Investor Brand Network ReShape Lifesciences™ Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 Conference Call to be Held at 8:00 am ET Today From ReShape Lifesciences Inc Via GlobeNewswire ReShape Lifesciences Announces $750,000 Registered Direct Offering November 08, 2022 From ReShape Lifesciences Inc Via GlobeNewswire Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga ReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update November 07, 2022 Conference Call to be Held at 8:00 am ET on Monday, November 14, 2022 From ReShape Lifesciences Inc Via GlobeNewswire ReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek® November 03, 2022 Stimulation of Vagus Celiac Fibers with Concurrent High Frequency Alternating Current Block of Hepatic Fibers Decreases Glucose Variability in a Swine Model of Type 2 Diabetes From ReShape Lifesciences Inc Via GlobeNewswire ReShape Lifesciences to Present at the Q4 Investor Summit November 02, 2022 From ReShape Lifesciences Inc Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday November 04, 2022 Friday's session saw 236 companies set new 52-week lows. Via Benzinga ReShape Lifesciences™ Announces That the ASMBS and IFSO Have Issued Updated Guidelines on Indications for Metabolic and Bariatric Surgery, Including the Lap-Band® October 31, 2022 From ReShape Lifesciences Inc Via GlobeNewswire ReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroScience October 25, 2022 From ReShape Lifesciences Inc Via GlobeNewswire ReShape Lifesciences™ Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS) October 20, 2022 From ReShape Lifesciences Inc Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session October 10, 2022 Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 04, 2022 On Tuesday, 44 companies hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 20, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session September 19, 2022 Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million. Via Benzinga Reshape Lifesciences's Return On Capital Employed Overview September 09, 2022 Benzinga Pro data, Reshape Lifesciences (NASDAQ:RSLS) reported Q2 sales of $2.89 million. Earnings fell to a loss of $9.58 million, resulting in a 16.57% decrease from last quarter. Via Benzinga Stocks That Hit 52-Week Lows On Friday September 02, 2022 On Friday, 122 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 16, 2022 On Tuesday, 37 stocks hit new 52-week lows. Via Benzinga Earnings Scheduled For August 15, 2022 August 15, 2022 Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. Via Benzinga Reshape Lifesciences Earnings Outlook August 12, 2022 Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Via Benzinga Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary August 10, 2022 Via Benzinga ReShape Lifesciences Shares Soar As FDA Announced Clearance To GIBI HD Calibration Tubes In Weight Loss Procedures August 10, 2022 The U.S. Food and Drug Administration (FDA) has announced 510(k) clearance to ReShape Lifesciences’ (NASDAQ: RSLS) Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for use in gastric and... Via Benzinga ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer July 27, 2022 From ReShape Lifesciences Inc Via GlobeNewswire This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session August 01, 2022 Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday July 27, 2022 Wednesday saw 83 companies set new 52-week lows. Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
